Abstract
Objectives
Oral lichen planus (OLP) is a chronic immune-mediated disease that affects the oral cavity. Topical steroids are considered the treatment of choice for painful lesions of OLP. The aim of this split-mouth study was to compare the efficacy of platelet-rich fibrin (PRF) and triamcinolone acetonide (TA) injective therapies in patients with symptomatic OLP.
Materials and methods
Participants with symptomatic OLP were recruited in the Academic Hospital of Magna Graecia University of Catanzaro, Italy. Once a week for a month, patients randomly received a 0.5-mL TA injection in one buccal mucosa and 1-mL PRF injection in the opposite side. The measured outcomes were reduction of the lesions area and symptomatology modifications using visual analogue scale (VAS) score
Results
Four weeks after the last injections, an average reduction of 59.8% in the lesion extension and an average reduction of 47.6% in the VAS score for PRF-treated sites were observed; the same variation for TA-treated sites was respectively of 59.2% and 40%. There were no statistically significant differences between the two groups.
Conclusions
PRF was effective in reducing OLP lesions extension and symptomatology, and it seems to be as effective as TA. Additional data should be collected with a larger sample size, at a longer follow-up and on the PRF lowest effective dose.
Clinical Relevance
Current treatment options for OLP are limited. The study proved benefits of PRF injections in management of painful lesions of OLP comparable with TA.
Similar content being viewed by others
References
Mollaoglu N (2000) Oral lichen planus: a review. Brit J Oral Maxillofacial Surg 38(4):370–377. https://doi.org/10.1054/bjom.2000.0555
Ismail SB, Kumar SKS, Zain RB (2007) Oral lichen planus and lichenoid reactions: etiopathogenesis, diagnosis, management and malignant transformation. J Oral Sci 49(2):89–106. https://doi.org/10.2334/josnusd.49.89
Thongprasom K, Carrozzo M, Furness S, Lodi G (2011) Interventions for treating oral lichen planus. Cochrane Database Syst Rev 6;(7):CD001168. https://doi.org/10.1002/14651858.cd001168.pub2
Alrashdan MS, Cirillo N, McCullough M (2016) Oral lichen planus: a literature review and update. Arch Dermatol Res 308(8):539–551. https://doi.org/10.1007/s00403-016-1667-2
Lodi G, Manfredi M, Mercadante V, Murphy R, Carrozzo M (2020) Interventions for treating oral lichen planus: corticosteroid therapies. Cochrane Database Syst Rev 28;2(2):CD001168. https://doi.org/10.1002/14651858.cd001168.pub3
Giudice A, Liborio F, Averta F, Barone S, Fortunato L (2019) Oral lichenoid reaction: an uncommon side effect of rituximab. Case Rep Dent 6;2019:3154856. https://doi.org/10.1155/2019/3154856
Dissemond J (2004) Oral lichen planus: an overview. J Dermatolog Treat 15:136–140. https://doi.org/10.1080/09546630410030720
Carbone M, Goss E, Carrozzo M, Castellano S, Conrotto D, Broccoletti R, Gandolfo S (2003) Systemic and topical corticosteroid treatment of oral lichen planus: a comparative study with long-term follow-up. J Oral Pathol Med 32(6):323–329. https://doi.org/10.1034/j.1600-0714.2003.00173.x
Lodi G, Scully C, Carrozzo M, Griffiths M, Sugerman PB, Thongprasom K (2005) Current controversies in oral lichen planus: report of an international consensus meeting. Part 2. Clinical management and malignant transformation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100:164–178. https://doi.org/10.1016/j.tripleo.2004.06.076
Ezzatt OM, Helmy IM (2019) Topical pimecrolimus versus betamethasone for oral lichen planus: a randomized clinical trial. Clin Oral Invest 23:947–956. https://doi.org/10.1007/s00784-018-2519-6
Zaslansky R, Schramm C, Stein C, Güthoff C, Schmidt-Westhausen AM (2018) Topical application of morphine for wound healing and analgesia in patients with oral lichen planus: a randomized, double-blind, placebo-controlled study. Clin Oral Invest 22:305–311. https://doi.org/10.1007/s00784-017-2112-4
Xia J, Li C, Hong Y, Yang L, Huang Y, Cheng B (2006) Short-term clinical evaluation of intralesional triamcinolone acetonide injection for ulcerative oral lichen planus. J Oral Pathol Med 35(6):327–331. https://doi.org/10.1111/j.1600-0714.2006.00441.x
Lee YC, Shin SY, Kim SW, Eun YG (2013) Intralesional injection versus mouth rinse of triamcinolone acetonide in oral lichen planus: a randomized controlled study. Otolaryngol Head Neck Surg 148(3):443–449. https://doi.org/10.1177/0194599812473237
Fantozzi PJ, Treister N, Shekar R, Woo SB, Villa A (2019) Intralesional triamcinolone acetonide therapy for inflammatory oral ulcers. Oral Surg Oral Med Oral Pathol Oral Radiol 128(5):485–490. https://doi.org/10.1016/j.oooo.2019.07.024
Casabona F, Priano, Vallerino V, Cogliandro A, Lavagnino G (2010) New surgical approach to lichen sclerosus of the vulva: the role of adipose-derived mesenchymal cells and platelet-rich plasma in tissue regeneration. Plast Reconstr Surg 126(4):210e-211e. 10.1097/prs.0b013e3181ea9386
Casabona F, Gambelli I, Casabona F, Santi P, Santori G, Baldelli I (2017) Autologous platelet rich plasma (PRP) in chronic penile lichen sclerosus: the impact on tissue repair and patient quality of life. Int Urol Nephrol 49:573–580. (a)
Bolanča Ž, Goren A, Getaldić-Švarc B, Vučić M (2016) Šitum M (2016) Platelet-rich plasma as a novel treatment for lichen planopillaris. Dermatol Ther 29(4):233–235. https://doi.org/10.1111/dth.12343
Piñas L, Alkhraisat MH, Fernández RS, Anitua E (2017) Biological therapy of refractory ulcerative oral lichen planus with plasma rich in growth factors. Am J Clin Dermatol 18(3):429–433. https://doi.org/10.1007/s40257-017-0277-x
Piñas L, Alkhraisat MH, Suárez-Fernández R, Anitua E (2018) Biomolecules in the treatment of lichen planus refractory to corticosteroid therapy: clinical and histopathological assessment. Ann Anat 216:159–163. https://doi.org/10.1016/j.aanat.2017.12.006
Bennardo F, Bennardo L, Del Duca E et al (2020) Autologous platelet-rich fibrin injections in the management of facial cutaneous sinus tracts secondary to medication-related osteonecrosis of the jaw. Dermatol Ther:e13334. https://doi.org/10.1111/dth.13334
Pandis N, Chung B, Scherer RW, Elbourne D, Altman DG (2017) CONSORT 2010 statement: extension checklist for reporting within person randomised trials. Bmj 357:j2835. https://doi.org/10.1136/bmj.j2835
Kramer IR, Lucas RB, Pindborg FF, Sobin LH (1978) Definition of leukoplakia and related lesions: an aid to studies on oral pre-cancer. Oral Surg Oral Med Oral Pathol 46:568–569
Fortunato L, Barone S, Bennardo F, Giudice A (2018) Management of facial pyoderma gangrenosum using platelet-rich fibrin: a technical report. J Oral Maxillofac Surg 76(7):1460–1463. https://doi.org/10.1016/j.joms.2018.01.012
Varela HA, Souza JCM, Nascimento RM, Araújo RF Jr, Vasconcelos RC, Cavalcante RS, Guedes PM, Araújo AA (2019) Injectable platelet rich fibrin: cell content, morphological, and protein characterization. Clin Oral Invest 23:1309–1318. https://doi.org/10.1007/s00784-018-2555-2
Thongprasom K, Luangjarmekorn L, Sererat T, Taweesap W (1992) Relative efficacy of fluocinolone acetonide compared with triamcinolone acetonide in treatment of oral lichen planus. J Oral Pathol Med 21:456–458. https://doi.org/10.1111/j.1600-0714.1992.tb00974.x
Scott J, Huskisson E (1976) Graphic representation of pain. Pain 2:175–184
Sugerman PB, Savage NW (2002) Oral lichen planus: causes, diagnosis and management. Aust Dent J 47(4):290–297. https://doi.org/10.1111/j.1834-7819.2002.tb00540.x
Li C, Tang X, Zheng X, Ge S, Wen H, Lin X, Chen Z, Lu L (2020) Global prevalence and incidence estimates of oral lichen planus: a systematic review and meta-analysis. JAMA Dermatol 156(2):172–181. https://doi.org/10.1001/jamadermatol.2019.3797
Zucoloto ML, Shibakura MEW, Pavanin JV, Garcia FT, da Silva Santos PS, Maciel AP, de Barros Gallo C, Souza NV, Innocentini LMAR, Humberto JSM, Motta ACF (2019) Severity of oral lichen planus and oral lichenoid lesions is associated with anxiety. Clin Oral Invest 23(12):4441–4448. https://doi.org/10.1007/s00784-019-02892-2
Payeras MR, Cherubini K, Figueiredo MA, Salum FG (2013) Oral lichen planus: focus on etiopathogenesis. Arch Oral Biol 58(9):1057–1069. https://doi.org/10.1016/j.archoralbio.2013.04.004
Edwards PC, Kelsch R (2002) Oral lichen planus: clinical presentation and management. J Can Dent Assoc 68(8):494–499
Stoppoloni G, Prisco F, Santinelli R, Sicuranza G, Giordano C (1983) Potential hazards of topical steroid therapy. Am J Dis Child 137:1130–1131. https://doi.org/10.1001/archpedi.1983.02140370086033
Bagan J, Compilato D, Paderni C et al (2012) Topical therapies for oral lichen planus management and their efficacy: a narrative review. Curr Pharm Des 18(34):5470–5480. https://doi.org/10.2174/138161212803307617
Giudice A, Esposito M, Bennardo F, Brancaccio Y, Buti J, Fortunato L (2019) Dental extractions for patients on oral antiplatelet: a within-person randomised controlled trial comparing haemostatic plugs, advanced-platelet-rich fibrin (A-PRF+) plugs, leukocyte-and platelet-rich fibrin (L-PRF) plugs and suturing alone. Eur J Oral Implantol 12(1):77–87
Fujioka-Kobayashi M, Katagiri H, Kono M, Schaller B, Zhang Y, Sculean A, Miron RJ (2020) Improved growth factor delivery and cellular activity using concentrated platelet-rich fibrin (C-PRF) when compared with traditional injectable (i-PRF) protocols. Clin Oral Invest 24:4373–4383. https://doi.org/10.1007/s00784-020-03303-7
Fortunato L, Bennardo F, Buffone C, Giudice A (2020) Is the application of platelet concentrates effective in the prevention and treatment of medication-related osteonecrosis of the jaw? A systematic review. J Craniomaxillofac Surg 48(3):268–285. https://doi.org/10.1016/j.jcms.2020.01.014
Gasparro R, Adamo D, Masucci M, Sammartino G, Mignogna MD (2019) Use of injectable platelet-rich fibrin in the treatment of plasma cell mucositis of the oral cavity refractory to corticosteroid therapy: a case report. Dermatol Ther 32(5):e13062. https://doi.org/10.1111/dth.13062
Miron RJ, Fujioka-Kobayashi M, Hernandez M, Kandalam U, Zhang Y, Ghanaati S, Choukroun J (2017) Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry? Clin Oral Investig 8:2619–2627. https://doi.org/10.1007/s00784-017-2063-9
Wang X, Zhang Y, Choukroun J, Ghanaati S, Richard J, Miron RJ (2017) Effects of an injectable platelet-rich fibrin on osteoblast behavior and bone tissue formation in comparison to platelet-rich plasma. Platelets 29(1):48–55. https://doi.org/10.1080/09537104.2017.1293807
Ni Riordain R, Hodgson PS, Fedele S (2016) Validity and reliability of the chronic oral mucosal diseases questionnaire in a UK population. J Oral Pathol Med 45(8):613–616. https://doi.org/10.1111/jop.12425
Arduino PG, Campolongo MG, Sciannameo V, Conrotto D, Gambino A, Cabras M, Ricceri F, Carossa S, Broccoletti R, Carbone M (2018) Randomized, placebo-controlled, double-blind trial of clobetasol propionate 0.05% in the treatment of oral lichen planus. Oral Dis 24(5):772–777. https://doi.org/10.1111/odi.12821
Author information
Authors and Affiliations
Contributions
Conceptualization: Francesco Bennardo, Amerigo Giudice; methodology: Francesco Bennardo, Francesco Liborio; formal analysis and investigation: Francesco Bennardo, Francesco Liborio, Alessandro Antonelli, Caterina Buffone; writing—original draft preparation: Francesco Bennardo, Francesco Liborio; writing—review and editing: Selene Barone, Caterina Buffone, Amerigo Giudice; supervision: Leonzio Fortunato, Amerigo Giudice.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Research involving human participants and/or animals
The ethical approval was obtained by the Ethical Review Board of Central Calabria (Prot. No. 23/2019).
Informed consent
All patients enrolled for the study signed an informed consent.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
ESM 1
(DOCX 45 kb)
Rights and permissions
About this article
Cite this article
Bennardo, F., Liborio, F., Barone, S. et al. Efficacy of platelet-rich fibrin compared with triamcinolone acetonide as injective therapy in the treatment of symptomatic oral lichen planus: a pilot study. Clin Oral Invest 25, 3747–3755 (2021). https://doi.org/10.1007/s00784-020-03702-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00784-020-03702-w